Suppr超能文献

子宫内膜异位症中作为抗炎候选药物的活性化合物的分子对接

Molecular Docking for Active Compounds of as Anti-inflammatory Candidate in Endometriosis.

作者信息

Yuniwati Cut, Ramli Nurlaili, Purwita Eva, Yusnaini Yusnaini, Nurdahliana Nurdahliana, Miko Ampera, Liana Intan, Andriani Andriani, Maharani Maharani

机构信息

Department of Midwifery, Polytechnic of Health, Ministry of Health, Aceh, Indonesia.

Department of Pharmacy, Polytechnic of Health, Ministry of Health, Aceh, Indonesia.

出版信息

Acta Inform Med. 2018 Dec;26(4):254-257. doi: 10.5455/aim.2018.26.254-257.

Abstract

INTRODUCTION

Endometriosis is still a problem for women all over the world. There are no studies that apply herbs, especially to inhibit the development of inflammation in endometriosis.

AIM

The purpose of this study was to analyze the docking of active ingredient of on NFkB-IkB complex with IKK way.

MATERIAL AND METHODS

The nine active ingredients of analyzed here were including aviculin (CID 10391477), caffeine (CID 2519), catechin (CID: 9064), epicatechin (CID: 72276), kaempferol (CID 5280863), quercetin (CID 5280343), quercitrin (CID 5280459)), rutin (CID 5280805), and theobromine (CID 5429). The sequence of study procedures included searching for amino acid sequences and active plant component structures, protein 3D structure modeling, docking and analysis of protein-ligand interaction.

RESULTS

Regarding the NFkB-IkB complex, it was found that all active ingredients can interact where the strongest interaction sequence was rutin (-314.35 kJ/mol). Regarding the interaction between IKK and NFkB-IkB, the nine active ingredients can reduce bond energy, except rutin.

CONCLUSIONS

the active ingredients of having the potential effect as anti-inflammatory is rutin so that it can be isolated and used as an alternative ingredient in inhibiting inflammation in endometriosis.

摘要

引言

子宫内膜异位症仍是全球女性面临的一个问题。目前尚无应用草药,尤其是抑制子宫内膜异位症炎症发展的相关研究。

目的

本研究旨在分析[具体草药名称未明确,原文此处可能有误]活性成分与NFkB-IkB复合物以IKK方式的对接情况。

材料与方法

此处分析的该草药的九种活性成分包括杨梅苷(CID 10391477)、咖啡因(CID 2519)、儿茶素(CID: 9064)、表儿茶素(CID: 72276)、山奈酚(CID 5280863)、槲皮素(CID 5280343)、槲皮苷(CID 5280459)、芦丁(CID 5280805)和可可碱(CID 5429)。研究程序序列包括搜索氨基酸序列和活性植物成分结构、蛋白质三维结构建模、蛋白质-配体相互作用的对接与分析。

结果

关于NFkB-IkB复合物,发现所有活性成分均可相互作用,其中相互作用最强的序列是芦丁(-314.35 kJ/mol)。关于IKK与NFkB-IkB之间的相互作用,除芦丁外,九种活性成分均可降低键能。

结论

该草药具有抗炎潜在作用的活性成分是芦丁,因此可将其分离出来用作抑制子宫内膜异位症炎症的替代成分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/296d/6311116/2d52a43b4c44/AIM-26-254-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验